Vertex Global Hc Fund Ii Pte. Ltd. Elevation Oncology, Inc. (ELEV) insider trading activity
Vertex Global Hc Fund Ii Pte. Ltd. is > 10% Shareholder of Elevation Oncology, Inc.. Currently has a direct ownership of 2.31 Million shares of ELEV, which is worth approximately $1.38 Million. The most recent transaction as insider was on Jun 29, 2021, when has been sold 250,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $4,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.31M
0%
3M change
0%
12M change
Total Value Held
$1.38 Million
Vertex Global HC Fund II Pte. Ltd. Transaction History
VGH
Vertex Global Hc Fund Ii Pte. Ltd.
> 10% Shareholder
Singapore, U0